Structural analogues of some highly active non-competitive AMPA antagonists

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Organic Synthesis

Background:

• AMPA receptors are crucial for synaptic plasticity and learning.
• Non-competitive AMPA antagonists are investigated for neurological disorders.
• GYKI 52466 is a well-established non-competitive AMPA antagonist.

Purpose of the Study:

• To synthesize novel 5-methyl analogues of existing non-competitive AMPA antagonists.
• To evaluate the biological activity of these new compounds.
• To identify potential therapeutic agents with improved or comparable efficacy to GYKI 52466.

Main Methods:

• Synthesis of 5-methyl analogues (14a-e) of 3-acylated 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-4,5-dihydro-3H-2,3-benzodiazepines.
• Biological activity screening of the synthesized compounds.
• Comparative analysis of activity against the reference compound GYKI 52466.

Main Results:

• The majority of the synthesized 5-methyl analogues exhibited diminished or low biological activity.
• Two specific derivatives, compounds 14a and 14b, displayed biological effects comparable to GYKI 52466.
• The structural modifications (5-methyl group) generally reduced, but did not abolish, antagonist activity.

Conclusions:

• The 5-methyl analogues of the studied benzodiazepine series generally possess reduced AMPA antagonist activity.
• Compounds 14a and 14b represent promising leads, retaining significant non-competitive AMPA antagonist properties.
• Further investigation into these active derivatives may yield novel therapeutic strategies for conditions involving AMPA receptor dysfunction.